In reply

Oncologist. 2014 Mar;19(3):307. doi: 10.1634/theoncologist.2013-0433.


A thorough description of cardiovascular events that might be noted with tyrosine kinase inhibitors would include a discussion of the pulmonary arterial hypertension but this focused review was intentionally limited to the most common cardiac events, including systemic hypertension, left ventricular dysfunction, and QT prolongation.

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases / pathology*
  • Drug-Related Side Effects and Adverse Reactions / therapy*
  • Humans
  • Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / adverse effects*


  • Protein Kinase Inhibitors